May 26th deadline to prequalify for FY2016 Md Biotech Investor Incentive Tax Credits
The electronic queue for the next round of Biotechnology Investor Incentive Tax Credits (50% of investment) will take place on July 1, 2015. To participate in this queue, companies must register by submitting their completed application (form A1/A2/A3 and form B) to DBED's Tax Incentives Group between June 1st and June 26th.  Companies seeking to prequalify (confirm their QMBC status) prior to June 1st may do so by submitting their company's information (form B) to DBED between May 18th and May 26th.  The $12M in credits available during FY2016 are awarded on a first come, first served basis. 

Gaithersburg's Emergent BioSolutions expands commercial product portfolio with FDA approval of IXINITY, a recombiant factor IX treatment for Hemophilia B.

Baltimore's Harpoon Medical enrolls initial three patients in early feasibility study of its repair system for off-pump, minimally invasive treatment of mitral valve regugitation ("MR").

Germantown's Zalgen Labs launches 1st rapid Ebola test approved by FDA (EUA) & WHO. 

Gaithersburg's Emergent BioSolutions, GenVec, Inc. and GlycoMimetics, Germantown's Intrexon and Neuralstem Inc., Columbia's Osiris Therapeutics, Inc., and Rockville's Synthetic Biologics announce first quarter 2015 financial results.

AstraZeneca/ MedImmune enter strategic immuno-oncology collaboration with Celgene Corporation to develop PD-L1 inhibitor program for patients with serious blood cancers.

Gaithersburg's Opgen launches IPO.

Baltimore's Biomecite Diagnostics signs agreement with UMB to develop IBD Dx tools.

Worcester farmer uses chicken waste as a power source (via ENST UMD news).

Columbia's Medifocus, Inc. closes $2.1M equity offering.

Baltimore's Noxilizer announces global supply agreement with Getinge-La Calhène.

Bethesda's Sucampo Pharmaceuticals' received FDA fast track approval for cobiprostone.

Gaithersburg's Vaxin announces study demonstrating its AdVAV vaccine has superior performance for protection against aerosolized anthrax.

Gaithersburg's Quality Biological receives grant from Montgomery County to support expansion of its operations.

Baltimore's Clear Guide Medical signs federal contract to test the Clear Guide One.

Silver Spring's PharamCyte Biotech, Inc. finalizes international consortium to cure diabetes.

FDA to require pharmaceutical applications to be submitted electronically.

NIH awards BioHealth Innovation, Inc. contract to mentor and train grantees of the National Institute of Neurological Disorders and Stroke.

2015 StartRight! business plan competition for women is accepting applicants thru 5/29. 

Do you have lab space (300 - 2K sq.ft.) to lease/sublet?  --Send details to BioMaryland.